首页 | 本学科首页   官方微博 | 高级检索  
检索        

活血化瘀法全程干预对慢性乙肝肝纤维化疗效的影响
引用本文:刘永芬,陈爱民,龚海龙,江一平.活血化瘀法全程干预对慢性乙肝肝纤维化疗效的影响[J].新中医,2010(1):37-38.
作者姓名:刘永芬  陈爱民  龚海龙  江一平
作者单位:江西中医学院临床技能中心;江西中医学院基础医学院学生办公室;江西省乐安县人民医院内二科;江西中医学院附属医院消化科;
摘    要:目的:观察活血化瘀法对慢性乙肝肝纤维化的临床疗效。方法:将90例患者随机分为常规组、治疗组和对照组各30例。分别给予相应治疗,观察肝功能指标、肝纤维化指标、药物不良反应及疗效。结果:临床疗效治疗组和对照组的基本治愈率均较常规组高,差异有显著性意义(P0.05)。治疗后3组肝功能各指标均有明显改善,与治疗前比较,差异均有显著性意义(P0.05)。治疗组治疗后肝功能各指标均较常规组明显改善,差异有显著性意义(P0.05)。对照组治疗后ALT、TBil、Alb均较常规组明显改善,差异有显著性意义(P0.05)。治疗后治疗组与对照组肝纤维化各指标均较治疗前明显下降,差异有显著性意义(P0.05);治疗组PⅢ较时照组明显下降,差异有显著性意义(P0.05)。治疗组HA、PⅢ、LN均较常规组治疗后明显下降,差异有显著性意义(P0.05)。对照组治疗后HA较常规组明显下降,差异有显著性意义(P0.05)。结论:活血化瘀法能保护肝功能,改善肝脏微循环,抑制胶原合成,促进肝纤维化溶解重吸收。

关 键 词:肝硬变  中医疗法  活血化瘀法(方)  肝功能  血清学指标

Therapeutic Effect of Whole-range Treatment with Blood-activating and Stasis-resolving Therapy for Chronic Hepatic Fibrosis After Hepatitis B
LIU Yongfen CHEN Aimin GONH Hailong.Therapeutic Effect of Whole-range Treatment with Blood-activating and Stasis-resolving Therapy for Chronic Hepatic Fibrosis After Hepatitis B[J].New Journal of Traditional Chinese Medicine,2010(1):37-38.
Authors:LIU Yongfen CHEN Aimin GONH Hailong
Abstract:Objective:To observe the therapeutic effect of whole-range treatment with blood-activating and stasis-resolving therapy(BST) for chronic hepatic fibrosis after hepatitis B.Methods:Ninety patients were equally randomized into 3 groups:routine treatment group,BST group and positive control group.After treatment, the changes of parameters of hepatic function and hepatic fibrosis were observed, and the side effect as well as therapeutic effect was evaluated.Results:The cure rate was higher in BST group and posi...
Keywords:
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号